• Contact us
  • Customer support
  • Login
  • Home
  • Technology
    • Introduction to Ex Vivo Lung Perfusion
    • The Ex Vivo Lung Perfusion Process
    • Clinical
    • Protocols
    • Starting your clinical EVLP program
    • Articles about EVLP
    • EVLP with Manual method
    • EVLP with XPS™
  • Products
    • Our Products
    • XPS™
    • XPS Disposable Lung Kit™
    • Steen Solution™
    • Perfadex®
    • Perfadex® Plus
    • XVIVO
      Silicone Tubing Set™
    • XVIVO LS™ & XVIVO Disposable Lung Set™
    • XVIVO
      Organ Chamber™
    • XVIVO
      Lung Cannula Set™
  • Knowledge
    • NOVEL Lung Trial
    • Literature
    • Insights
    • Movies
  • Media
    • Videos
    • Webinars
  • About us
    • About Xvivo
    • History
    • Training and workshops
    • Our market
    • News
    • Career
    • Working at XVIVO Perfusion
  • Corporate
    • Corporate
    • The share
    • Press releases
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financial calendar
    • Financial reports
    • Prospectus and material offerings
      • Material offerings
      • Prospectus
    • Financial presentations
    • Corporate governance
      • Article of Association
      • General meetings
      • Board of Directors
      • Senior Management
      • Auditors
      • Board Committees
      • Board and Senior Management share holdings
      • Guidelines for remuneration
      • Nomination Committee
      • Corporate Governance Reports
    • Analyst Coverage
    • CODE OF CONDUCT
    • Privacy policy
    • Subscribe
    • Thank you
    • Error
XVIVO Perfusion
  • Contact us
  • Customer support
  • Home
  • Technology
    • Introduction to Ex Vivo Lung Perfusion
    • The Ex Vivo Lung Perfusion Process
    • Clinical
    • Protocols
    • Starting your clinical EVLP program
    • Articles about EVLP
    • EVLP with Manual method
    • EVLP with XPS™
  • Products
    • Our Products
    • XPS™
    • XPS Disposable Lung Kit™
    • Steen Solution™
    • Perfadex®
    • Perfadex® Plus
    • XVIVO
      Silicone Tubing Set™
    • XVIVO LS™ & XVIVO Disposable Lung Set™
    • XVIVO
      Organ Chamber™
    • XVIVO
      Lung Cannula Set™
  • Knowledge
    • NOVEL Lung Trial
    • Literature
    • Insights
    • Movies
  • Media
    • Videos
    • Webinars
  • About us
    • About Xvivo
    • History
    • Training and workshops
    • Our market
    • News
    • Career
    • Working at XVIVO Perfusion
  • Corporate
    • Corporate
    • The share
    • Press releases
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financial calendar
    • Financial reports
    • Prospectus and material offerings
      • Material offerings
      • Prospectus
    • Financial presentations
    • Corporate governance
      • Article of Association
      • General meetings
      • Board of Directors
      • Senior Management
      • Auditors
      • Board Committees
      • Board and Senior Management share holdings
      • Guidelines for remuneration
      • Nomination Committee
      • Corporate Governance Reports
    • Analyst Coverage
    • CODE OF CONDUCT
    • Privacy policy
    • Subscribe
    • Thank you
    • Error

News Tag: Q1

09 Apr 2020

Strong cash flow despite the influence of Covid-19

  • 05:30

FIRST QUARTER 2020 (JAN – MAR)

Read more
09 Apr 2020

Starkt kassaflöde trots påverkan av Covid-19

  • 05:30

FÖRSTA KVARTALET 2020 (JAN – MAR)

Read more
24 Apr 2019

STRONG GROWTH IN WARM PERFUSION AND PROGRESS IN THE R&D PORTFOLIO

  • 05:30

FIRST QUARTER 2019 (JAN – MAR)

Read more
24 Apr 2019

HÖG TILLVÄXT FÖR VARM PERFUSION OCH FRAMSTEG INOM FoU-PORTFÖLJEN

  • 05:30

FÖRSTA KVARTALET 2019 (JAN – MAR)

Read more
26 Apr 2018

XVIVO Perfusion AB (publ) delårsrapport januari – mars 2018

  • 05:00

REKORDFÖRSÄLJNING UNDER KVARTALET OCH GOD EBITDA

Read more
  • «
  • 1
  • 2
  • 3
  • 4
  • »

Archive

  • March 2019
  • October 2018
  • September 2018
  • May 2018
  • February 2018
  • January 2018
  • June 2016
  • May 2016
  • April 2016
  • February 2016
  • January 2016
  • July 2015

Categories

  • Uncategorized
About us

XVIVO Perfusion is a medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation.

Contact

Swedish Office
XVIVO Perfusion AB
Box 53015
SE-400 14 Göteborg
Sweden

Phone: +46 31 788 21 50
Fax: +46 31 788 21 69
info@xvivoperfusion.com

Newsletter

I have read and accepted XVIVO Perfusion's Privacy Policy

*By signing up to our newsletter you consent to XVIVO Perfusion sending you our insights newsletter and occasional additional communications. Your personal data will be transfered to a third party newsletter distributor engaged by XVIVO Perfusion. All processing of your personal data is in compliance with the XVIVO Perfusion Privacy Policy. For more information on how we use your personal data, please read XVIVO Perfusion’s Privacy policy

  • Home
  • Technology
  • Products
  • Knowledge
  • Media
  • About us
  • Corporate

Copyright © 2020 XVIVO Perfusion. All rights reserved.

Design mkmedia
To top

We use cookies to improve the user experience on XVIVO Perfusion. Read more about Cookies

Approve